Literature DB >> 14662806

Managing skin and soft tissue infections: expert panel recommendations on key decision points.

Lawrence J Eron1, Benjamin A Lipsky, Donald E Low, Dilip Nathwani, Alan D Tice, Gregory A Volturo.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14662806     DOI： 10.1093/jac/dkg466

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  66 in total

Review 1.  Infections.

Authors:  Brendan Healy; Andrew Freedman
Journal:  BMJ       Date:  2006-04-08

2.  Tissue penetration of telavancin after intravenous administration in healthy subjects.

Authors:  Heather K Sun; Kenneth Duchin; Charles H Nightingale; Jeng-Pyng Shaw; Julie Seroogy; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.

Authors:  H David Friedland; Tanya O'Neal; Donald Biek; Paul B Eckburg; Douglas R Rank; Lily Llorens; Alex Smith; Gary W Witherell; Joseph B Laudano; Dirk Thye
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

4.  Diagnosis and management of cellulitis.

Authors:  Tadhg Sullivan; Eoghan de Barra
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

5.  Trends in resource utilization for hospitalized children with skin and soft tissue infections.

Authors:  Michelle A Lopez; Andrea T Cruz; Marc A Kowalkowski; Jean L Raphael
Journal:  Pediatrics       Date:  2013-02-25       Impact factor: 7.124

6.  Prospective study of the Wilson severity-of-illness scoring system for complicated skin and skin structure infections.

Authors:  George H Talbot; Tanya O'Neal; Anita F Das; Dirk Thye
Journal:  Antimicrob Agents Chemother       Date:  2012-11-05       Impact factor: 5.191

7.  Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles.

Authors:  Evan M Hetrick; Jae Ho Shin; Heather S Paul; Mark H Schoenfisch
Journal:  Biomaterials       Date:  2009-02-23       Impact factor: 12.479

8.  Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infections.

Authors:  W T Prince; Z Ivezic-Schoenfeld; C Lell; K J Tack; R Novak; F Obermayr; G H Talbot
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

9.  Abscesses and wound infections due to Staphylococcus lugdunensis: report of 16 cases.

Authors:  N Papapetropoulos; M Papapetropoulou; A Vantarakis
Journal:  Infection       Date:  2012-12-16       Impact factor: 3.553

10.  Empirical antibiotics use in soft tissue infections.

Authors:  Rodger Shortt; Achilleas Thoma
Journal:  Can J Plast Surg       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.